Not applicableStudy completedNCT05714371
What this trial is testing
Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
Who this might be right for
Melanoma
Novartis Pharmaceuticals 618